HK
Harry Kovelman
Chief Medical Officer

Harry Kovelman insider trades: Myomo (MYO) stock buys and sales

Chief Medical Officer, Myomo Last trade Sep 11, 2026 64 Form 4 filings
$102K
Sold, last 12 months
4 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2023
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Harry reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 11, 2026MYO↓ Sell$20K
Sep 11, 2026MYO↓ Sell$20K
Aug 20, 2026MYO↓ Sell$30K
May 28, 2026MYO↓ Sell$32K
Mar 12, 2025MYO↓ Sell$165K
Sep 5, 2024MYO↓ Sell$25K
Sep 3, 2024MYO↓ Sell$8K
May 15, 2024MYO↓ Sell$131K
Aug 29, 2023MYO↑ Buy$5K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other MYO insiders

Open-market trades in the last 12 months

About Harry Kovelman's insider trades

Harry Kovelman is Chief Medical Officer at Myomo (MYO). Since Aug 29, 2023, Harry has reported 1 open-market purchase worth $5K and 8 sales worth $431K on SEC Form 4. In the last 12 months: 4 sales ($102K).

Their filings also include shares withheld for taxes (49 filings), grants and awards (10 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MYO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.